Background The purpose of this article is to describe neonatal intensive care unit clinician perceptions of a continuous predictive analytics technology and how those perceptions influenced clinician adoption. Adopting and integrating new technology into care is notoriously slow and difficult; realizing expected gains remain a challenge. Methods Semistructured interviews from a cross-section of neonatal physicians (n ¼ 14) and nurses (n ¼ 8) from a single U.S. medical center were collected 18 months following the conclusion of the predictive monitoring technology randomized control trial. Following qualitative descriptive analysis, innovation attributes from Diffusion of Innovation Theory-guided thematic development. Results Results suggest that the combination of physical location as well as lack of integration into work flow or methods of using data in care decisionmaking may have delayed clinicians from routinely paying attention to the data. Once data were routinely collected, documented, and reported during patient rounds and patient handoffs, clinicians came to view data as another vital sign. Through clinicians' observation of senior physicians and nurses, and ongoing dialogue about data trends and patient status, clinicians learned how to integrate these data in care decision making (e.g., differential diagnosis) and came to value the technology as beneficial to care delivery. Discussion The use of newly created predictive technologies that provide early warning of illness may require implementation strategies that acknowledge the risk-benefit of treatment clinicians must balance and take advantage of existing clinician training methods.
Background and Significance
New technologies, such as predictive analytics, hold the potential to dramatically improve knowledge about illnesses and their effective treatment.
1-4 Predictive technologies are designed to assess for and warn of patient risk hours to days in advance of clinical signs toward the goals of early clinical intervention and improved patient outcomes. [5] [6] [7] [8] However, risk of illness does not guarantee a patient will develop that illness, thus clinicians must balance the benefits of early intervention (e.g., resolving infection prior to sepsis onset) with the negative consequences of delayed treatment or unnecessary treatment (e.g., developing antibiotic-resistant organisms). To date, predictive analytics studies primarily focused on statistical model development and accuracy, rather than on clinicians' acceptance and adoption of predictive technologies into care. [9] [10] [11] [12] [13] [14] Among studies that did evaluate clinician use, results underscore clinicians' difficulty in translating risk prediction into medically actionable interventions. 6, 15 Known technology implementation challenges (e.g., poor design, 16 misalignment between system design and care processes, [17] [18] [19] [20] [21] [22] [23] [24] changes to communication and care processes 25 ) may further complicate use of these emerging innovations, negatively impact efficacy trials, 26, 27 and delay systematic adoption. 6 This article describes neonatal intensive care unit (NICU) clinician perceptions of a continuous predictive analytics technology and how those perceptions influenced clinician adoption.
Continuous Predictive Analytics: Heart Rate Observation
Using streaming electrocardiograph (ECG) monitoring heart rate data (RR interval, sample asymmetry, standard deviation, and calculations of sample entropy) from bedside monitoring technology, a University of Virginia (UVA) interdisciplinary team (neonatology, cardiology, statistics, biomedical engineering) developed mathematical algorithms to discriminated neonatal sepsis and sepsis-like illness. 28 The team then created a monitor to visualize the algorithm, heart rate observation (HeRO), a predictive analytics technology and refined technology functions in response to neonatologist feedback (►Fig. 1). HeRO calculated and displayed a neonate's fold-increased risk of developing sepsis in the next 24 hours where a score of 1 represents baseline sepsis risk among all neonates. This score was known as the heart rate characteristic (HRC) index. Updated hourly, the monitor was designed to display a 5-day trend (►Fig. 1: orange, top) and indicate highest HRC (►Fig. 1: yellow vertical line) with corresponding raw heart rate data (►Fig. 1: green, bottom) with controls to allow users to scroll back through time.
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Following Food and Drug Administration approval, the HeRO research team conducted a parallel, two-group, individually randomized control trial (RCT) (NCT00307333) among 3,003 very low birth weight (< 1,500 g) neonates from 9 U.S. NICUs to determine if HeRO improved neonatal sepsis outcomes. 29 At UVA, a single HeRO monitor (►Fig. 1) was mounted in a central location in each of six pods to maximize visibility from the 6 to 9 beds contained in each pod. At the beginning of the clinical trial (April, 2004) , the research team provided NICU clinicians with information regarding how the score was calculated and that a rising score might indicate the need to assess the patient and, as needed, to test or treat as appropriate. 29 The research team did not use other implementation strategies (e.g., programmatic training, decision aids, treatment protocols) to promote or improve provider engagement with HeRO or to influence the use of HeRO data in clinical care due to concerns about unnecessary sepsis evaluations or overuse Fig. 1 Heart rate observation (HeRO) monitor-visualizing heart rate characteristics index, corresponding heart rate pattern, and controls to scroll forward and backward in time.
of blood cultures and antibiotics. 
Methods Study Design
This study employed a cross-sectional qualitative descriptive design using individual interviews collected from an academic NICU in central Virginia. 42 Participants were recruited through a convenience sampling strategy that included any point of care clinician (registered nurse, respiratory therapist, nurse practitioner, attending physician) who worked in the unit and were exposed to the HeRO display monitoring for any period of time. There were no exclusion criteria. 
Participants
Following permission from the UVA NICU medical director, NICU members (nurses, nurse practitioners, and resident, fellow, and attending physicians) were contacted by email inviting participation in a qualitative study of medical decisionmaking using HeRO. A follow-up email was sent 2weeks later. Respondents were scheduled for in-person or telephonic semistructured interviews during January and February 2012. Consent was obtained from each participant at the 
Data Collection
Following an interview guide (►Appendix A), semistructured interviews with open-ended questions were conducted in-person and telephonically, audio recorded, transcribed verbatim, and imported into ATLAS.ti (Scientific Software Development GmbH, Berlin, Germany). These data were not subsequently analyzed due to study staff turnover.
Data Analysis
Because these data were collected to answer a different research question, R.A., R.K., C.L., and J.M. read five interviews (registered nurse, nurse practitioner, resident, fellow, and attending) to determine if appropriate data existed to answer study aims. 43, 44 Due to the open-ended nature of the questions and the topics covered in the interview guide, this preliminary review found descriptions of participants' perceptions of HeRO, interactions with HeRO, and use of HeRO data in practice.
Informed by the desire to understand NICU clinicians' perceptions of HeRO and the relationship between perceptions and subsequent adoption of HeRO, the team developed four broad a priori codes to explore how clinicians first became aware of HeRO (awareness); learned to interpret HeRO data (interpretation); used HeRO (use); and how HeRO data guided care decisions and actions (decision-making and action). 45 The team then read a subset of interviews and identified additional codes to capture contextual information about professional roles and routines, and care responsibilities. Following code and code definition agreement, the teams were divided into pairs to conduct descriptive analysis using the full code book. Each interview was read in its entirety by both coders, and then in a second reading, codes were applied to text segments. Coding pairs conducted code agreement meetings at two separate times during the coding process. The entire team met on a weekly basis to review code level text segments, evolving memos, and emerging themes. Guided by Miles et al, 46 text segments were abstracted for each code into matrices as matrices facilitate sorting and grouping segments to identify themes informed by DOI's five innovation attributes. The team frequently returned to original material to uncover assumptions and explore alternate hypotheses. The team used four strategies to enhance trustworthiness: (1) multiple team members coded the same interview data with cross-validation of code use; (2) assumptions and questions about the data were captured in memos and reviewed with the team; (3) all aspects of the study design were open for review by the members of the research team; and (4) all members used ATLAS.ti to provide an audit trail.
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Results
The 22 participants represented a cross-section of healthcare professionals: registered nurses (n ¼ 3), nurse practitioners (n ¼ 3), resident physicians (n ¼ 3), neonatology fellows (n ¼ 4), and neonatology attending physicians (n ¼ 7). Participants ranged in professional experience from 2 to 30 years and worked in the UVA NICU between 1 month and 15 years. Seven participants were employed at the inception of the clinical trial, seven joined during the clinical trial, and six joined after the trial concluded. No participants were members of the UVA research team. Participants' perceptions of HeRO are organized according to the five DOI innovation attributes (complexity, compatibility, trialability, observability, relative advantage) (►Table 2).
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Complexity
Innovations that are easily understood and used, can be learned incrementally, or can be experimented with are more likely to be adopted. 37 At clinical trial inception, participants (n ¼ 9)
reported receiving a brief presentation provided by a member of the HeRO research team. This presentation described the monitor's function and score meaning: the fold-increased risk that a neonate will develop sepsis in the next 24 hours. Although participants received initial information about the display and score, participants did not know whether a changing score should drive clinical decision making or whether it should merely contribute to overall clinical impressions. A neonatology fellow reflected on the introduction of technology into care, suggesting that use may take more than simply understanding how predictive data are calculated and what the data represents: "Until somebody says to you and takes you by the hand…this is how to approach these screens; these are the questions you can answer with this technology, I won't use it just cause it's there." Prior to HeRO's introduction, users were accustomed to making care decisions based on physiologic data that provided information on the neonate's current status (i.e., respiratory rate, heart rate, laboratory values, etc.). Because this was the first application of HeRO in a clinical environment, participants had no experience with HeRO scores or their association with patient symptoms. Neither could participants rely on other members of the care team to help them learn about or use HeRO. This lack of experience may have negatively affected initial engagement with HeRO data. In fact, the lack of use was pervasive across the entire care team. It appears that participants' initial engagement with the data was not influenced by knowledge about HeRO provided when the monitors were installed or by the monitors' presence on the unit.
Compatibility
Innovations that align with users' values, needs, or past experiences are more likely to be adopted. 33, 34, 37 Clinicians noted that the location of HeRO differed from the location of other devices they used in day-to-day care delivery. Physiologic monitors that displayed heart and respiratory rates, oxygenation, blood pressure, etc., resided at each neonate's bedside. The single HeRO display was centrally located in each pod. To see the data, clinicians describe the need to move away from the bedside, stand on "tippy toes," or to walk to the monitor. Thus, physical location may have deterred routine engagement with HeRO. The research team and unit managers agreed to undertake initial steps to increase participant attention to the HeRO "Then the nurses were told if the HeRO score goes up by a certain amount they need to alert a clinician-a nurse practitioner, or a resident, or a fellow, or an attending." (Attending)
"…routine care involves vital signs every so many hours, depending upon your patient population, and the HeRO score is a part of vital signs monitoring." (RN)
"It actually now appears automatically. There's a way to automatically get it put into the progress note. Even just in the last six months when I've been rounding with Epic, I've noticed that the residents are much more aware of what the HeRO score is and what it means than they were three years ago." (Attending) Communication "We actually had the fellows responsible for reviewing the HeRO trending overnight so they would know what might have transpired with the baby's monitoring overnight. So that would be part of their presentation. Even if it's the matter of the HeRO remains below two they were looking at it." (Attending)
"You know, I'm trying to think of who doesn't use it. We're a pretty-it's pretty engrained in our practice at this point that everybody, even in our report as nurses when we hand off, will make a comment; HeRO stable or HeRO went up overnight, but this is what we're doing about it. So I really can't talk to very many instances where it hasn't come up." RN
Trialability
Clinical reasoning "…especially at the beginning when it was over two we were doing a full blown workup, I felt like there was a lot of unnecessary workups. That just in itself predisposes the baby to-you stick in a catheter in their urethra, you probably-a little bit more prone to bladder infections then." (Nurse Practitioner)
"On call at night when there's a kid that's not doing well, we have some suspicion of sepsis, the nurse practitioners or the fellows would take a look at the HeRO monitors. score, yet refrained from requesting specific care interventions in response to the data. Participants described strategies that align with or were compatible with routine care practices. Nurses were instructed to record the score every 4 hours and alert nurse practitioners and physicians if the score reached two or increased by two. Fellows were required to observe and report on score trends and care actions during morning patient rounds. These strategies appear to have influenced participant "…I'm giving tours at the NICU to families and they're worried about their baby hooked up to these monitors-what's reassuring to some of them is saying "Here is the monitor, here are all the numbers we're looking at and we're getting data on your baby. I'm not even touching your baby. I'm not poking or prodding your baby. I can see what the heart rate is, I can see what the respiratory pattern is, see what the blood pressure is, … we have all these methods of evaluating your baby without having to wake the baby up and take a blood sample. I think the HeRO is one of those ways that we can assess the baby without hurting the baby so to speak.an advantage is not hurting the baby." (RN)
"There really was not anything like Hero that they used before in terms of its predictive quality. the only close comparison is a human caregiver having an instinct that something MIGHT happen." (Fellow)
Evidence base "I know there has been a recent review in [journal] by [doctor]. I have not had a chance to read that. But we talk about HeRO all the time. Before they present some data in big national meetings." (Attending)
"[The published study] has shown that it makes a difference, and we obviously believe in it strongly here, so we pay attention when the HeRO goes above two." (Nurse Practitioner)
"We're always proud to say it's the biggest randomized clinical trial of very low birth weight infants ever with 3,000 patients. The fact that that showed mortality reduction, I mean there's really not much that reduces mortality in preemies." (Attending)
Abbreviations: CBC, complete blood count; DOI, Diffusion of Innovation; HeRO, heart rate observation; NICU, neonatal intensive care unit; RN, Registered Nurse.
behavior as noted by one nurse practitioner, "Having the nurses writing it down was key to us being successful in reacting appropriately to the spikes and so forth as they happen. I think that was a turning point." At first, nurses documented HeRO data on the paper vital signs flow sheet, then later in the electronic health record. Similarities between HeRO and vital signs collection pattern (every 4 hours) or its documentation in close proximity to vital signs data eventually caused nurses to view HeRO as a vital sign. Prior to these requirements, HeRO data did not have a place in the routine assessment, documentation, or daily conversations about patients. Overtime, data collection and communication became embedded in care routines and team interactions.
The trialability, or the ability of participants to experiment 37 with HeRO during the RCT, allowed for a more nuanced understanding of the application to develop over the course of the study. Several attendings and nurse practitioners observed that initial reactions to rising HeRO scores may have led to unnecessary testing due to inexperience. "… especially at the beginning when it [HeRO Score] was over two we were doing a full blown workup, I felt like there was a lot of unnecessary workups" (nurse practitioner). They attribute this perception to inexperience with HeRO as well as clinical inexperience among some team members.
The clinical team eventually learned that a score of two or a rise of two did not necessarily mean that a neonate had sepsis. Through documentation and data presentation during patient rounds, HeRO data became integrated as a component of the overall dataset routinely used in care decision making. Further, participants eventually learned that not all neonates with rising HeRO scores would develop sepsis. As they gained experience, participants developed critical judgment about the relationship between HeRO scores and signs to guide when to undertake diagnostic testing and treatment. Over time, participants came to rely on the score to help them understand uncertain emerging symptoms and used HeRO in ongoing communication and decision making about next care interventions.
Observability
The more readily a user can see or observe the results of using an innovation, the more likely it will be adopted. 37 Members of the NICU also learned how to interpret and react to HeRO data by observing the practices of more experienced clinicians. Less experienced clinicians observed if and how senior participants used HeRO data. "[Attending] spent some time explaining to me what it is, how it works, how you can look at it…so, just learning in which clinical aspects would you do this versus that I've learned from the attendings" (fellow). Less experienced participants appear to have benefited most when senior members shared how they use HeRO data in care decision making. Both less experienced as well new members of the NICU reported observing the practices of experienced participants to figure out how to interpret and use HeRO data in care delivery.
Relative Advantage
Observable, substantiated advantage of an innovative and newly introduced technology is seen as a pivotal attribute for influencing its adoption. 37 In the case of HeRO, there was no evidence base or even experienced participants upon whom the NICU team could rely. Through interaction with the data and observation of neonatal symptoms and outcomes, HeRO data served different purposes for different types of participants. For example, the data confirmed nurses' emerging clinical impressions and helped nurses determine when to share their observations to other members of the care team. Physicians came to expect nurses to use HeRO data when communicating about a patient's status. The inclusion of HeRO data in nurses' communication about patients seemed to serve as a trigger for physician team members because this may have prompted patient assessment or closer examination of patient data. Over time, participants recognized the benefit of noninvasive, continuous monitoring. As evidence from the RCT emerged, NICU clinicians identified themselves as contributors to a significant improvement in neonatal care delivery. RCT findings may also have served to reinforce that participants made the correct decision to use HeRO in care delivery as it implies that use has scientific merit.
Discussion
This study examined NICU clinicians' perceptions of a predictive analytics monitoring technology following the conclusion of the RCT establishing its efficacy. In light of the novel nature of HeRO, evidence of effectiveness as well as guidance for its application in care delivery was limited.
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Use of prediction in care delivery often requires a balance between the benefits and risk of taking action. Consistent with DOI research, study results suggest that HeRO's attributes were key to influencing its use in the NICU. The findings highlight participants' initial reaction to HeRO, the effect of minimal prompts on participant engagement with HeRO data, how the care team learned to interpret and use HeRO to guide care decisions, and how the benefits, or relative advantage, of HeRO data emerged over time with experience.
Reduce Complexity: Provide Simple Guidelines for Engaging with HeRO
Knowledge about the usefulness of an innovation may not be sufficient to promote an innovation's use. Although sepsis remains a significant cause of death for neonates, the presence of HeRO in relative proximity to the bedside was insufficient to promote use among study participants. Prior research indicates that if an innovation is difficult to use or understand, adoption may occur slowly or not at all.
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Because HeRO provided an early alert for the increasing potential for sepsis, but was not a definitive test for sepsis, participants may have had difficulty knowing if and when an increasing HeRO score warranted medical action. Combined with the physical location of HeRO, difficulty interpreting the score in the context of care delivery may have been a contributing factor for the initial lack of attention. Simple, mandated interaction with the data, such as documenting and communicating, increased both written and verbal visibility and was seen by study participants as a turning point. Further, guidelines for when to report score changes, a "call out" procedure, likely reduced nurse uncertainty or worry about raising false alarms and engaged several types of care providers in the evaluation of HeRO trends and patient status. Call out procedures, a type of decision aid, are associated with effective clinician communication, early care intervention, 49 and reduced mortality among hospitalized patients. 50 However, several participants expressed concern that initial reactions to HeRO led to unnecessary sepsis work-ups. The RCT did note a nonsignificant increase in blood cultures and antibiotics 29 ; it may be that the concern voiced by more experienced clinicians actually curtailed overreaction to rising HeRO scores. Decision aids, such as the one described in our study, may promote engagement, while avoiding mandated care actions and may provide a more effective means of introducing predictive analytics technologies into complex healthcare settings. 
Strengths and Limitations
Study limitations include generalizability, strong interest in HeRO at UVA, small sample size, and recall bias. While selecting participants from a single hospital unit limits generalizability, this units' extensive experience with HeRO allowed us to explore the experience of implementing a newly developed technology. Our participants were the first to be recruited into the RCT, the first to encounter HeRO data and knowledge in the care environment, and therefore, had the greatest experiences to share with the study team. Although our sample was small, it represented a crosssection of professions, neonatal experience, tenure on unit, and experience with HeRO. Due to the wide variation in experience with HeRO, we achieved thematic saturation only in terms of HeRO use in clinical decisionmaking: HeRO was a "piece of the puzzle," on data point among many considered when developing a medical course of action. Because participant interviews took place a year following the conclusion of the clinical trial, participant data were at risk for recall bias. However, we found consistent descriptions of the original implementation; the strategies unit managers first established; as well as how members learned through role modeling and dialog across participants. A next step to understanding the use of HeRO in hospitals might include direct observation of care team actions. Finally, this study examined a single type of prediction, sepsis, a particularly persistent, devastating illness. Future research efforts should consider evaluating other types of negative patient experiences, such as hemorrhage, where early intervention is associated with improved survival.
Conclusion
Other than a handful of prediction studies, the majority focused on model development and validation, therefore there is little evidence to guide integrating predictive data into providers' care routines. 11, 27 Tools such as the Acute Physiology and Chronic Health Evaluation, are typically used to benchmark ICU quality and not alert providers to patient decline. 11 Further, there is little evidence to guide interventions to promote clinician acceptance and use of predictive technologies as the majority of studies focus upon model development and accuracy, not on providers' acceptance of prediction as an element of care decision making. 9, 11, 14, 62, 63 The correct answer is option c. In general, integration into workflow is essential for implementation of any kind of technology, evidenced-based practice, or care protocol. While other options provide knowledge about an innovation, integration provides opportunities to develop skills.
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